Madrigal Pharmaceuticals, Inc. Completes Its Merger With Synta Pharmaceuticals Corp.

Represented Madrigal Pharmaceuticals, Inc. in its merger with Synta Pharmaceuticals Corp. 

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic and liver diseases.